Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Feifel

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Journal of Visualized Experiments : Jove|October 22, 2016
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coilDavid Feifel, Katherine Pappas
Postgraduate Medicine|October 1, 2008
Attention-deficit/hyperactivity disorder in adults: recognition and diagnosis of this often-overlooked conditionDavid Feifel, Kai MacDonald
Current Psychiatry Reports|June 15, 2010
Promise and pitfalls of animal models of schizophreniaDavid Feifel, Paul D Shilling
CNS Drugs|February 20, 2016
Potential of Oxytocin in the Treatment of SchizophreniaPaul D Shilling, David Feifel
The Journal of Clinical Psychiatry|May 4, 2006
A systematic review of modafinil: Potential clinical uses and mechanisms of actionJacob S Ballon, David Feifel
Pharmacology, Biochemistry, and Behavior|June 26, 2008
The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startlePaul D Shilling, David Feifel
Schizophrenia Research|September 29, 2006
The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patientsArpi Minassian, David Feifel, William Perry
Journal of Affective Disorders|August 13, 2004
Prepulse inhibition in patients with non-psychotic major depressive disorderWilliam Perry, Arpi Minassian, David Feifel
Journal of Psychiatric Research|August 5, 2008
Prepulse inhibition of startle in adults with ADHDDavid Feifel, Arpi Minassian, William Perry
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2004
Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effectsDavid Feifel, Gilia Melendez, Paul D Shilling
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Journal of Visualized Experiments : Jove|October 22, 2016
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coilDavid Feifel, Katherine Pappas
Postgraduate Medicine|October 1, 2008
Attention-deficit/hyperactivity disorder in adults: recognition and diagnosis of this often-overlooked conditionDavid Feifel, Kai MacDonald
Current Psychiatry Reports|June 15, 2010
Promise and pitfalls of animal models of schizophreniaDavid Feifel, Paul D Shilling
CNS Drugs|February 20, 2016
Potential of Oxytocin in the Treatment of SchizophreniaPaul D Shilling, David Feifel
The Journal of Clinical Psychiatry|May 4, 2006
A systematic review of modafinil: Potential clinical uses and mechanisms of actionJacob S Ballon, David Feifel
Pharmacology, Biochemistry, and Behavior|June 26, 2008
The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startlePaul D Shilling, David Feifel
Schizophrenia Research|September 29, 2006
The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patientsArpi Minassian, David Feifel, William Perry
Journal of Affective Disorders|August 13, 2004
Prepulse inhibition in patients with non-psychotic major depressive disorderWilliam Perry, Arpi Minassian, David Feifel
Journal of Psychiatric Research|August 5, 2008
Prepulse inhibition of startle in adults with ADHDDavid Feifel, Arpi Minassian, William Perry
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2004
Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effectsDavid Feifel, Gilia Melendez, Paul D Shilling
Pageof 12